Myoinositol in adolescent polycystic ovary syndrome
The MAP Trial is looking at Polycystic Ovary Syndrome (PCOS), a common hormone problem affecting teenage girls. PCOS can cause irregular periods, acne, and excess hair. Current treatments often use hormones, which some young people prefer to avoid. This study aims to see if a natural food supplement called myoinositol could be a helpful alternative. While myoinositol has shown promise in adults, it hasn't been properly studied in teenagers. This is a small first study to check if a larger trial to test how well the supplement works is possible. It will involve girls aged 12-19 with PCOS taking either myoinositol or a dummy pill for 6 months, alongside lifestyle advice, to see how practical the study is.
Överblick
Vad handlar denna studie om?
Polycystic Ovary Syndrome, or PCOS, is a common condition that affects many teenage girls. It happens when hormones in the body are a bit out of balance. This can lead to various symptoms that can be really bothersome, like irregular periods, acne, and extra hair growth. For some, it can also cause feelings of distress or worry. Beyond these daily challenges, PCOS can also increase the risk of some health problems later in life, such as diabetes and heart disease.
At the moment, treatments for PCOS often involve medicines that affect hormones. However, some young people and their families might prefer not to use these, perhaps due to worries about side effects or personal beliefs. This particular study, called the MAP Trial, wants to explore another option: a natural food supplement called myoinositol. This supplement has looked promising in studies with adult women who have PCOS, but we don't yet know if it's helpful and safe for teenagers.
It’s important to understand that this study is a 'feasibility study'. This means it’s not designed to tell us if myoinositol definitely works better than current treatments right now. Instead, it’s a vital first step to figure out if it’s practical and possible to run a much bigger study in the future that *would* properly test how well the supplement works. We need to check things like how many girls are willing to take part, how well they stick to the treatment, and if we can easily gather all the necessary information. What we learn from this study will help us plan a bigger, more definite trial later on.
Viktiga punkter
- It's a study for teenage girls (12-19) with PCOS.
- It tests a natural supplement called myoinositol as a possible alternative treatment.
- This is a 'feasibility study' – checking if a bigger study is possible, not if it definitely works yet.
- You'll take either myoinositol or a dummy pill for 6 months.
- Involves 3 hospital visits for checks and questionnaires.
- Aims to improve future PCOS care for teenagers.
Vem kan vara berättigad?
This study is looking for teenage girls aged between 12 and 19 years old. To take part, you need to have a confirmed diagnosis of Polycystic Ovary Syndrome (PCOS) from a doctor. This diagnosis usually involves having irregular periods and showing signs of higher male hormones, like significant hair growth or severe acne.
There are also some reasons why you wouldn't be able to join. For example, if you're already taking medicines specifically for PCOS, or if you've used certain hormones or myoinositol in the last three months, you wouldn't be eligible. The study also can't include you if your symptoms are caused by other medical conditions that mimic PCOS, or if you have certain allergies, can't swallow tablets, or can't read or write in English.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- Am I aged between 12 and 19 years old?
- Has a doctor confirmed I have PCOS?
- Do I have irregular periods OR signs of higher male hormones (like significant hair or severe acne)?
- Am I NOT currently taking any PCOS medication or hormonal treatments?
- Have I NOT used myoinositol in the last 3 months?
- Am I able to swallow tablets?
Vad innebär deltagande?
If you decide to take part in this study, you'll be joining for 6 months. You will be put into one of two groups by chance, like flipping a coin – you won't get to choose. One group will take the myoinositol supplement twice a day, and the other group will take a placebo (a dummy pill that looks the same but has no active ingredient) twice a day. No one, not even the doctors, will know which tablet you are taking until the end of the study.
You'll also receive general advice on healthy living. Throughout the 6 months, you'll have three routine appointments at the hospital. These appointments will involve checking your symptoms, completing some questionnaires about your well-being and daily life (which should take about 10-15 minutes each time), and having some routine blood tests. Some participants and their parents will also be asked if they'd like to talk about their experiences in an interview, to help us understand how to improve future research.
Potentiella risker och fördelar
Platser (6)
- Birmingham Childrens HospitalObekräftadBirmingham, England
- Birmingham Womens HospitalObekräftadBirmingham, England
- Liverpool Women's HospitalObekräftadLiverpool, England
- Alder Hay Childrens HospitalObekräftadLiverpool, England
- St Michaels HospitalObekräftadBristol, England
- Norfolk & Norwich University HospitalObekräftadNorwich, England
Vanliga frågor
What is PCOS?
PCOS, or Polycystic Ovary Syndrome, is a common hormone condition that can cause problems like irregular periods, acne, and extra hair growth in teenage girls.
What is myoinositol?
Myoinositol is a natural food supplement that has shown some promise in helping adults with PCOS symptoms.
Kommer jag att veta om jag tar det riktiga tillskottet eller en sockerpiller?
No, you won't know. Participants are randomly assigned, and neither you nor the doctors will know whether you are taking myoinositol or a placebo until the study is over.
Hur länge kommer jag att vara involverad i studien?
You'll be involved for 6 months, during which you'll take the tablets daily and attend three routine appointments.
Var äger denna studie rum?
The study is running from six NHS hospitals in England, including Birmingham, Liverpool, Norwich, and Bristol, and is organised by the University of Birmingham.
Hur du får reda på mer
Rachel Iles
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Intresserad av att delta?
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.